Table of Contents Chapter 1 Biosimilar Monoclonal Antibodies Market Overview 1.1 Biosimilar Monoclonal Antibodies Definition 1.2 Global Biosimilar Monoclonal Antibodies Market Size Status and Outlook (2014-2029) 1.3 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Region (2014-2029) 1.4 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Type (2014-2029) 1.5 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Application (2014-2029) 1.6 Global Biosimilar Monoclonal Antibodies Market Size Comparison by Sales Channel (2014-2029) 1.7 Biosimilar Monoclonal Antibodies Market Dynamics (COVID-19 Impacts) 1.7.1 Market Drivers/Opportunities 1.7.2 Market Challenges/Risks 1.7.3 Market News (Mergers/Acquisitions/Expansion) 1.7.4 COVID-19 Impacts on Current Market 1.7.5 Post-Strategies of COVID-19 Outbreak Chapter 2 Biosimilar Monoclonal Antibodies Market Segment Analysis by Player 2.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Player (2017-2019) 2.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Player (2017-2019) 2.3 Global Biosimilar Monoclonal Antibodies Average Price by Player (2017-2019) 2.4 Players Competition Situation & Trends 2.5 Conclusion of Segment by Player Chapter 3 Biosimilar Monoclonal Antibodies Market Segment Analysis by Type 3.1 Global Biosimilar Monoclonal Antibodies Market by Type 3.1.1 Infliximab 3.1.2 Rituximab 3.1.3 Trastuzumab 3.1.4 Adalimumab 3.1.5 Other 3.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2014-2019) 3.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2014-2019) 3.4 Global Biosimilar Monoclonal Antibodies Average Price by Type (2014-2019) 3.5 Leading Players of Biosimilar Monoclonal Antibodies by Type in 2019 3.6 Conclusion of Segment by Type Chapter 4 Biosimilar Monoclonal Antibodies Market Segment Analysis by Application 4.1 Global Biosimilar Monoclonal Antibodies Market by Application 4.1.1 Oncology 4.1.2 Autoimmune Disease 4.1.3 Other 4.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Application (2014-2019) 4.3 Leading Consumers of Biosimilar Monoclonal Antibodies by Application in 2019 4.4 Conclusion of Segment by Application Chapter 5 Biosimilar Monoclonal Antibodies Market Segment Analysis by Sales Channel 5.1 Global Biosimilar Monoclonal Antibodies Market by Sales Channel 5.1.1 Direct Channel 5.1.2 Distribution Channel 5.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Sales Channel (2014-2019) 5.3 Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies by Sales Channel in 2019 5.4 Conclusion of Segment by Sales Channel Chapter 6 Biosimilar Monoclonal Antibodies Market Segment Analysis by Region 6.1 Global Biosimilar Monoclonal Antibodies Market Size and CAGR by Region (2014-2029) 6.2 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Region (2014-2019) 6.3 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Region (2014-2019) 6.4 North America 6.4.1 North America Market by Country 6.4.2 North America Biosimilar Monoclonal Antibodies Market Share by Type 6.4.3 North America Biosimilar Monoclonal Antibodies Market Share by Application 6.4.4 United States 6.4.5 Canada 6.4.6 Mexico 6.5 Europe 6.5.1 Europe Market by Country 6.5.2 Europe Biosimilar Monoclonal Antibodies Market Share by Type 6.5.3 Europe Biosimilar Monoclonal Antibodies Market Share by Application 6.5.4 Germany 6.5.5 UK 6.5.6 France 6.5.7 Italy 6.5.8 Russia 6.5.9 Spain 6.6 Asia-Pacific 6.6.1 Asia-Pacific Market by Country 6.6.2 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Type 6.6.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Share by Application 6.6.4 China 6.6.5 Japan 6.6.6 Korea 6.6.7 India 6.6.8 Southeast Asia 6.6.9 Australia 6.7 South America 6.7.1 South America Market by Country 6.7.2 South America Biosimilar Monoclonal Antibodies Market Share by Type 6.7.3 South America Biosimilar Monoclonal Antibodies Market Share by Application 6.7.4 Brazil 6.7.5 Argentina 6.7.6 Colombia 6.8 Middle East & Africa 6.8.1 Middle East & Africa Market by Country 6.8.2 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Type 6.8.3 Middle East & Africa Biosimilar Monoclonal Antibodies Market Share by Application 6.8.4 UAE 6.8.5 Saudi Arabia 6.8.6 South Africa 6.9 Conclusion of Segment by Region Chapter 7 Profile of Leading Biosimilar Monoclonal Antibodies Players 7.1 Celltrion 7.1.1 Company Snapshot 7.1.2 Product/Service Offered 7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share) 7.1.4 COVID-19 Impact on Celltrion 7.2 Pfizer (Hospira) 7.3 3SBIO 7.4 Novartis (Sandoz) 7.5 Dr Reddy’s 7.6 Celgen Biopharma 7.7 Cadila Healthcare 7.8 Hisun Pharma 7.9 Torrent Pharmaceuticals Chapter 8 Upstream and Downstream Analysis of Biosimilar Monoclonal Antibodies 8.1 Industrial Chain of Biosimilar Monoclonal Antibodies 8.2 Upstream of Biosimilar Monoclonal Antibodies 8.2.1 Raw Materials 8.2.2 Labor Cost 8.2.3 Manufacturing Expenses 8.2.4 Manufacturing Cost Structure 8.2.5 Manufacturing Process 8.3 Downstream of Biosimilar Monoclonal Antibodies 8.3.1 Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies 8.3.2 Leading Consumers of Biosimilar Monoclonal Antibodies Chapter 9 Development Trend of Biosimilar Monoclonal Antibodies (2020-2029) 9.1 Global Biosimilar Monoclonal Antibodies Market Size (Sales and Revenue) Forecast (2020-2029) 9.2 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Region (2020-2029) 9.3 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Type (2020-2029) 9.4 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Application (2020-2029) 9.5 Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Sales Channel (2020-2029) Chapter 10 Appendix 10.1 Research Methodology 10.2 Data Sources 10.3 Disclaimer 10.4 Analysts Certification

List of Tables and Figures Figure Biosimilar Monoclonal Antibodies Example Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Status and Outlook (2014-2029) Figure Global Biosimilar Monoclonal Antibodies Revenue (Million $) Comparison by Region (2014-2029) Figure Global Biosimilar Monoclonal Antibodies Sales Comparison by Type (2014-2029) Figure Global Biosimilar Monoclonal Antibodies Sales Comparison by Application (2014-2029) Figure Global Biosimilar Monoclonal Antibodies Sales Comparison by Sales Channel (2014-2029) Table Global Biosimilar Monoclonal Antibodies Sales by Player (2017-2019) Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Player (2017-2019) Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Player in 2019 Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Player (2017-2019) Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Player (2017-2019) Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Player in 2019 Table Global Biosimilar Monoclonal Antibodies Average Price by Player (2017-2019) Figure Global Biosimilar Monoclonal Antibodies Average Price by Player in 2019 Figure Global Biosimilar Monoclonal Antibodies Players Competition Situation – Top 5 Players’ Revenue Market Share in 2017 Figure Global Biosimilar Monoclonal Antibodies Players Competition Trends – Top 5 Players’ Revenue Market Share in 2019 Figure Example of Infliximab Figure Global Infliximab Sales and Growth Rate (2014-2019) Figure Example of Rituximab Figure Global Rituximab Sales and Growth Rate (2014-2019) Figure Example of Trastuzumab Figure Global Trastuzumab Sales and Growth Rate (2014-2019) Figure Example of Adalimumab Figure Global Adalimumab Sales and Growth Rate (2014-2019) Figure Example of Other Figure Global Other Sales and Growth Rate (2014-2019) Table Global Biosimilar Monoclonal Antibodies Sales by Type (2014-2019) Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2014-2019) Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019 Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Type (2014-2019) Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2014-2019) Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type in 2019 Table Global Biosimilar Monoclonal Antibodies Average Price by Type (2014-2019) Figure Global Biosimilar Monoclonal Antibodies Average Price by Type in 2019 Table Leading Players of Biosimilar Monoclonal Antibodies by Type in 2019 Figure Example of Oncology Figure Global Biosimilar Monoclonal Antibodies for Oncology Sales and Growth Rate (2014-2019) Figure Example of Autoimmune Disease Figure Global Biosimilar Monoclonal Antibodies for Autoimmune Disease Sales and Growth Rate (2014-2019) Figure Example of Other Figure Global Biosimilar Monoclonal Antibodies for Other Sales and Growth Rate (2014-2019) Table Global Biosimilar Monoclonal Antibodies Sales by Application (2014-2019) Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2014-2019) Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019 Table Leading Consumers of Biosimilar Monoclonal Antibodies by Application in 2019 Figure Example of Direct Channel Figure Global Biosimilar Monoclonal Antibodies for Direct Channel Sales and Growth Rate (2014-2019) Figure Example of Distribution Channel Figure Global Biosimilar Monoclonal Antibodies for Distribution Channel Sales and Growth Rate (2014-2019) Table Global Biosimilar Monoclonal Antibodies Sales by Sales Channel (2014-2019) Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Sales Channel (2014-2019) Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Sales Channel in 2019 Table Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies by Sales Channel in 2019 Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR by Region (2014-2029) Table Global Biosimilar Monoclonal Antibodies Sales by Region (2014-2019) Table Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2014-2019) Figure Global Biosimilar Monoclonal Antibodies Sales Market Share by Region in 2019 Table Global Biosimilar Monoclonal Antibodies Revenue (Million $) by Region (2014-2019) Table Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2014-2019) Figure Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region in 2019 Table North America Biosimilar Monoclonal Antibodies Sales by Country (2014-2019) Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2014-2019) Table North America Biosimilar Monoclonal Antibodies Revenue by Country (2014-2019) Figure North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2014-2019) Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019 Figure North America Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019 Figure United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure United States Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Canada Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Mexico Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Table Europe Biosimilar Monoclonal Antibodies Sales by Country (2014-2019) Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country (2014-2019) Table Europe Biosimilar Monoclonal Antibodies Revenue by Country (2014-2019) Figure Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2014-2019) Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019 Figure Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019 Figure Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Germany Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure UK Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure France Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Italy Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Russia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Spain Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Spain Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Table Asia-Pacific Biosimilar Monoclonal Antibodies Sales by Country (2014-2019) Figure Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Country (2014-2019) Table Asia-Pacific Biosimilar Monoclonal Antibodies Revenue by Country (2014-2019) Figure Asia-Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2014-2019) Figure Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019 Figure Asia-Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019 Figure China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure China Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Japan Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Korea Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure India Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Southeast Asia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Australia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Australia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Table South America Biosimilar Monoclonal Antibodies Sales by Country (2014-2019) Figure South America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2014-2019) Table South America Biosimilar Monoclonal Antibodies Revenue by Country (2014-2019) Figure South America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2014-2019) Figure South America Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019 Figure South America Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019 Figure Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Brazil Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Argentina Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Argentina Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Colombia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Colombia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Table Middle East & Africa Biosimilar Monoclonal Antibodies Sales by Country (2014-2019) Figure Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country (2014-2019) Table Middle East & Africa Biosimilar Monoclonal Antibodies Revenue by Country (2014-2019) Figure Middle East & Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2014-2019) Figure Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019 Figure Middle East & Africa Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019 Figure UAE Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure UAE Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure Saudi Arabia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure Saudi Arabia Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Figure South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2014-2019) Figure South Africa Biosimilar Monoclonal Antibodies Revenue (Million $) and Growth Rate (2014-2019) Table Company Snapshot of Celltrion Table Biosimilar Monoclonal Antibodies Introduction of Celltrion Table Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share of Celltrion (2017-2019) Table Industrial Chain of Biosimilar Monoclonal Antibodies Table Manufacturing Cost Structure of Biosimilar Monoclonal Antibodies Table General Manufacturing Process of Biosimilar Monoclonal Antibodies Table Leading Distributors/Dealers of Biosimilar Monoclonal Antibodies Table Leading Consumers of Biosimilar Monoclonal Antibodies Figure Global Biosimilar Monoclonal Antibodies Sales and Growth Rate Forecast (2020-2029) Figure Global Biosimilar Monoclonal Antibodies Revenue and Growth Rate Forecast (2020-2029) Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Region (2020-2029) Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Type (2020-2029) Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Application (2020-2029) Table Global Biosimilar Monoclonal Antibodies Market Size and CAGR Forecast by Sales Channel (2020-2029)

Celltrion Pfizer (Hospira) 3SBIO Novartis (Sandoz) Dr Reddy’s Celgen Biopharma Cadila Healthcare Hisun Pharma Torrent Pharmaceuticals